Yuan Xu
CIK 1858214 · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$17.9K
Companies
3
Total Filings
20
Lifetime Open-Market Net
-$24.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-15 | FATE | Sell (S) | −3,460 | -$19.3K | EDGAR |
| 2023-06-13 | XLO | Grant (A) | — | $0 | EDGAR |
| 2023-06-07 | FATE | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | XLO | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | FATE | Grant (A) | +8,650 | $0 | EDGAR |
| 2022-06-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-06 | XLO | Grant (A) | — | $0 | EDGAR |
| 2021-08-05 | FATE | Grant (A) | +4,744 | $0 | EDGAR |
| 2021-06-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-26 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.